These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 24866020)
1. Multifaceted activities of type I interferon are revealed by a receptor antagonist. Levin D; Schneider WM; Hoffmann HH; Yarden G; Busetto AG; Manor O; Sharma N; Rice CM; Schreiber G Sci Signal; 2014 May; 7(327):ra50. PubMed ID: 24866020 [TBL] [Abstract][Full Text] [Related]
2. Fine Tuning of a Type 1 Interferon Antagonist. Urin V; Levin D; Sharma N; Harari D; Schreiber G PLoS One; 2015; 10(7):e0130797. PubMed ID: 26158644 [TBL] [Abstract][Full Text] [Related]
3. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Hwang SY; Hertzog PJ; Holland KA; Sumarsono SH; Tymms MJ; Hamilton JA; Whitty G; Bertoncello I; Kola I Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11284-8. PubMed ID: 7479980 [TBL] [Abstract][Full Text] [Related]
4. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007 [TBL] [Abstract][Full Text] [Related]
5. Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R. Harris BD; Schreiter J; Chevrier M; Jordan JL; Walter MR J Biol Chem; 2018 Oct; 293(41):16057-16068. PubMed ID: 30171073 [TBL] [Abstract][Full Text] [Related]
6. The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities. Kalie E; Jaitin DA; Podoplelova Y; Piehler J; Schreiber G J Biol Chem; 2008 Nov; 283(47):32925-36. PubMed ID: 18801736 [TBL] [Abstract][Full Text] [Related]
7. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons. Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298 [TBL] [Abstract][Full Text] [Related]
8. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1. Xia C; Vijayan M; Pritzl CJ; Fuchs SY; McDermott AB; Hahm B J Virol; 2015 Dec; 90(5):2403-17. PubMed ID: 26676772 [TBL] [Abstract][Full Text] [Related]
9. Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ. Stifter SA; Matthews AY; Mangan NE; Fung KY; Drew A; Tate MD; Soares da Costa TP; Hampsey D; Mayall J; Hansbro PM; Garcia Minambres A; Eid SG; Mak J; Scoble J; Lovrecz G; deWeerd NA; Hertzog PJ J Biol Chem; 2018 Mar; 293(9):3168-3179. PubMed ID: 29187603 [TBL] [Abstract][Full Text] [Related]
10. Type I IFN family members: similarity, differences and interaction. Capobianchi MR; Uleri E; Caglioti C; Dolei A Cytokine Growth Factor Rev; 2015 Apr; 26(2):103-11. PubMed ID: 25466633 [TBL] [Abstract][Full Text] [Related]
11. Antiviral responses in mouse embryonic stem cells: differential development of cellular mechanisms in type I interferon production and response. Wang R; Wang J; Acharya D; Paul AM; Bai F; Huang F; Guo YL J Biol Chem; 2014 Sep; 289(36):25186-98. PubMed ID: 24966329 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of type III interferon expression. Iversen MB; Paludan SR J Interferon Cytokine Res; 2010 Aug; 30(8):573-8. PubMed ID: 20645874 [TBL] [Abstract][Full Text] [Related]
13. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes. Zaritsky LA; Bedsaul JR; Zoon KC J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085 [TBL] [Abstract][Full Text] [Related]
14. Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response. Lasfar A; Cook JR; Cohen Solal KA; Reuhl K; Kotenko SV; Langer JA; Laskin DL Immunology; 2014 Jul; 142(3):442-52. PubMed ID: 24597649 [TBL] [Abstract][Full Text] [Related]
15. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939 [TBL] [Abstract][Full Text] [Related]
16. Differential expression and activity of the porcine type I interferon family. Sang Y; Rowland RR; Hesse RA; Blecha F Physiol Genomics; 2010 Jul; 42(2):248-58. PubMed ID: 20406849 [TBL] [Abstract][Full Text] [Related]
17. Differential receptor subunit affinities of type I interferons govern differential signal activation. Jaks E; Gavutis M; Uzé G; Martal J; Piehler J J Mol Biol; 2007 Feb; 366(2):525-39. PubMed ID: 17174979 [TBL] [Abstract][Full Text] [Related]
18. Beyond Good and Evil: Molecular Mechanisms of Type I and III IFN Functions. Dowling JW; Forero A J Immunol; 2022 Jan; 208(2):247-256. PubMed ID: 35017214 [TBL] [Abstract][Full Text] [Related]
19. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities. Subramaniam PS; Khan SA; Pontzer CH; Johnson HM Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883 [TBL] [Abstract][Full Text] [Related]
20. Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression. Lubick KJ; Robertson SJ; McNally KL; Freedman BA; Rasmussen AL; Taylor RT; Walts AD; Tsuruda S; Sakai M; Ishizuka M; Boer EF; Foster EC; Chiramel AI; Addison CB; Green R; Kastner DL; Katze MG; Holland SM; Forlino A; Freeman AF; Boehm M; Yoshii K; Best SM Cell Host Microbe; 2015 Jul; 18(1):61-74. PubMed ID: 26159719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]